Digital therapeutics

Northeast Delta HSA partners with Department of Health, Foundation for Wellness to host webinar series "Utilizing Digital Therapeutics"

Retrieved on: 
Wednesday, March 13, 2024
Single-frequency network, Health, Information technology, Digital, Partnership, Physician, Diabetes, DSM-IV codes, Knowledge, Lead, Research, CME, Therapy, Wellness, Digital technology, Thibodeaux, Cholesterol, Multimedia, Nursing, Social, Digital therapeutics, Hypertension

MONROE, La., March 13, 2024 /PRNewswire-PRWeb/ -- Northeast Delta Human Services Authority (NEDHSA), in partnership with the Louisiana Department of Health and Foundation for Wellness, announced a new webinar series on Utilizing Digital Therapeutics (DTx). This series will delve into the power of Digital Therapeutics, an evidence-based software intervention that can prevent, manage, and treat various behavioral health conditions. The six-part webinar series will occur between March and August 2024.

Key Points: 
  • Northeast Delta Human Services Authority (NEDHSA), in partnership with the Louisiana Department of Health and Foundation for Wellness, announced a new webinar series on Utilizing Digital Therapeutics (DTx).
  • This series will delve into the power of Digital Therapeutics, an evidence-based software intervention that can prevent, manage, and treat various behavioral health conditions.
  • MONROE, La., March 13, 2024 /PRNewswire-PRWeb/ -- Northeast Delta Human Services Authority (NEDHSA), in partnership with the Louisiana Department of Health and Foundation for Wellness, announced a new webinar series on Utilizing Digital Therapeutics (DTx).
  • This series will delve into the power of Digital Therapeutics, an evidence-based software intervention that can prevent, manage, and treat various behavioral health conditions.

NCPDP Foundation Opens Its Call for Grant Proposals, Due April 30

Retrieved on: 
Wednesday, February 28, 2024
Innovation, Digital therapeutics, Pharmacogenomics, Social, Pharmacist, Chesley Bonestell, MST, Health, Patient safety, Fund, Medicine, HL7, Trustee, Arrangement, Request, Standard, Value, Role, Single-frequency network, Health equity, Pharmaceutical industry

SCOTTSDALE, Ariz., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its call for grant proposals that demonstrate the value of NCPDP standards in supporting the expanded role of pharmacists, patient safety, access to care, and coordination of care and innovation. Proposals must meet the grant proposal requirements and be submitted electronically by 5:00 p.m. MST on April 30, 2024, to be considered for the current grant funding cycle.

Key Points: 
  • SCOTTSDALE, Ariz., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced its call for grant proposals that demonstrate the value of NCPDP standards in supporting the expanded role of pharmacists, patient safety, access to care, and coordination of care and innovation.
  • Proposals must meet the grant proposal requirements and be submitted electronically by 5:00 p.m. MST on April 30, 2024, to be considered for the current grant funding cycle.
  • Grant projects must benefit at least one of the NCPDP Foundation strategic initiatives: expanding the role and value of the pharmacist ; expanding patient access to care ; enhancing patient safety ; and empowering coordination of care and innovation, its newest strategic initiative.
  • To submit a grant proposal, complete and submit the Request for Funding form along with supplemental material by 5:00 p.m. MST on April 30, 2024.

Digital Therapeutics (DTx) Market Worth $21.9 Billion | MarketsandMarkets™

Retrieved on: 
Tuesday, January 23, 2024
Diabetes, Obesity, Digital therapeutics, Market development, Patient, Research, Incidence, Pulse, Diet, Roe, Growth, Digital, Software, B2B, Single-frequency network, Investment, Habit, Conditional sentence, Prevalence, Therapy, Substance abuse, Prediabetes, Direct-to-consumer, Pharmaceutical industry

The sales channel segment in the digital therapeutics market is categorized into business-to-business (B2B) and business-to-customer (B2C).

Key Points: 
  • The sales channel segment in the digital therapeutics market is categorized into business-to-business (B2B) and business-to-customer (B2C).
  • Digital Therapeutics (DTx) Market Dynamics:
    Key Market Players of Digital Therapeutics (DTx) Industry:
    Prominent players in the digital therapeutics market include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Biofourmis (US), Better Therapeutics, Inc (US), Amalgm Rx (US), CogniFit Inc (US), Headspace Health (US), Propeller Health (US), Virta Health Corp (US), 2Morrow, Inc. (US), Realizedcare (US), Canary Health (US), Twill Inc. (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt.
  • Market Development: Comprehensive information detailing lucrative market – the report analyses the digital therapeutics market across various regions as well as countries.
  • Market Diversification: Exhaustive information about new software and programs, untapped geographies, recent developments, and investments in the digital therapeutics market.

National Sleep Foundation Launches SleepTech® Network

Retrieved on: 
Tuesday, January 9, 2024
National Sleep Foundation, Digital therapeutics, Mobility, Sleep, Health, Booth, NSF, Waymo, Samsung Health, Therapy, Doctor of Philosophy, Organization, Education, Pharmaceutical industry

LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- The National Sleep Foundation (NSF) today launched its SleepTech® Network, a new community forum for stakeholders across the sleep technology industry. The announcement comes from CES® in Las Vegas, a trade show that showcases the entire tech landscape. NSF is exhibiting at Booth 8604 in the North Hall in Tech East.

Key Points: 
  • LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- The National Sleep Foundation (NSF) today launched its SleepTech® Network , a new community forum for stakeholders across the sleep technology industry.
  • NSF's SleepTech Network benefits members through education, insights, and access, including to NSF resources and each other.
  • Each organization can stay informed and up-to-date with the latest NSF research and data on sleep health technology, while network members learn about advances with other professionals in the field of SleepTech, discuss sleep technology issues and opportunities, and interact with peers at NSF-hosted educational events.
  • NSF has promoted positive sleep health through published expert recommendations, consensus guidelines, technology standards, and easy-to-use tips and tools to improve sleep.

Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors

Retrieved on: 
Friday, December 1, 2023
Digital therapeutics, Johnson & Johnson, Biotechnology, GE Research, Autoimmunity, Rheumatology, Internal medicine, Inflammation, Therapy, University, Medical college, Scleroderma, Publication, Patient, University of Toledo, Janssen Pharmaceuticals, Pharmaceutical industry

NEW YORK and BOSTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D.

Key Points: 
  • NEW YORK and BOSTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D.
  • to the Akari Board of Directors.
  • “Samir is a long-time investor in Akari and brings to us broad life sciences experience and a track record of multiple successful startup companies.
  • I am pleased to welcome him to our Board of Directors at this important time in our company’s development,” said Ray Prudo, M.D., Akari Chairman.

Dx&Vx co-develops a bio-healthcare big data platform with LG CNS

Retrieved on: 
Wednesday, December 20, 2023
Cloud, Google Cloud, Single-frequency network, Stem cell, Digital, Digital therapeutics, Medicine, CVS, Drug development, Research, CDSS, Disease, Blood, Tissue, DNA, Cancer, CDX, AI, GSK, Artificial intelligence, LG CNS, Biomarker, Therapy, LG, Medical device

SEOUL, South Korea, Dec. 20, 2023 /PRNewswire/ -- Dx&Vx will develop a bio-healthcare big data platform utilizing AI technology provided by LG CNS.

Key Points: 
  • Dx&Vx recently announced on the 18th that it has signed a contract with LG CNS to jointly develop a bio-healthcare big data platform utilizing AI technology provided by LG CNS.
  • Dx&Vx is set to introduce an AI-driven digital medical and clinical data platform through its collaboration with LG CNS.
  • LG CNS will provide the AI and big data technologies needed to build the platform.
  • Starting with the joint development, Dx&Vx plans to strengthen its collaboration with LG CNS to develop innovative bio-healthcare solutions based on its biomedical big data platform.

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

Retrieved on: 
Thursday, November 16, 2023
Health, PNE, Acquisition, Chronic pain, Digital therapeutics, PatientsLikeMe, Hospital, Patient, Medication, Movement, Fear, Therapy, Massachusetts General Hospital, Pain, Mindfulness, VR, DSM-IV codes, Quality of life, Single-frequency network, Education, Poultry farming, Nursing

NASHVILLE, Tenn. and AACHEN, Germany, Nov. 16, 2023 /PRNewswire/ -- BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern Health, a virtual chronic pain management program, today announced the signing of an agreement to merge their businesses and create a new digital care management solution for chronic pain. The new offering will be branded as RealizedCare, and strives to meet the increased demand for evidence-based, more scalable, impactful and economically viable solutions for a range of mental and behavioral health burdens, beginning with chronic pain.

Key Points: 
  • RealizedCare introduces an advanced care management platform powered by DTx technology.
  • The platform's approach, which combines DTx with traditional wraparound services, will unlock value-based chronic pain management at scale.
  • "Chronic pain is on the rise globally and the demand for holistic, multi-modal care via digital solutions is growing.
  • "We are thrilled to join RealizedCare and to enable this new offering, which supercharges the scalability and economic viability of traditional care management programs," said Brad Lawson, CEO, Fern Health.

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

Retrieved on: 
Thursday, November 16, 2023
Health, PNE, Acquisition, Chronic pain, Digital therapeutics, PatientsLikeMe, Hospital, Patient, Medication, Movement, Fear, Therapy, Massachusetts General Hospital, Pain, Mindfulness, VR, DSM-IV codes, Quality of life, Single-frequency network, Education, Poultry farming, Nursing

NASHVILLE, Tenn. and AACHEN, Germany, Nov. 16, 2023 /PRNewswire/ -- BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern Health, a virtual chronic pain management program, today announced the signing of an agreement to merge their businesses and create a new digital care management solution for chronic pain. The new offering will be branded as RealizedCare, and strives to meet the increased demand for evidence-based, more scalable, impactful and economically viable solutions for a range of mental and behavioral health burdens, beginning with chronic pain.

Key Points: 
  • RealizedCare introduces an advanced care management platform powered by DTx technology.
  • The platform's approach, which combines DTx with traditional wraparound services, will unlock value-based chronic pain management at scale.
  • "Chronic pain is on the rise globally and the demand for holistic, multi-modal care via digital solutions is growing.
  • "We are thrilled to join RealizedCare and to enable this new offering, which supercharges the scalability and economic viability of traditional care management programs," said Brad Lawson, CEO, Fern Health.

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

Retrieved on: 
Thursday, November 16, 2023
Health, PNE, Acquisition, Chronic pain, Digital therapeutics, PatientsLikeMe, Hospital, Patient, Medication, Movement, Fear, Therapy, Massachusetts General Hospital, Pain, Mindfulness, VR, DSM-IV codes, Quality of life, Single-frequency network, Education, Poultry farming, Nursing

NASHVILLE, Tenn. and AACHEN, Germany, Nov. 16, 2023 /PRNewswire/ -- BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern Health, a virtual chronic pain management program, today announced the signing of an agreement to merge their businesses and create a new digital care management solution for chronic pain. The new offering will be branded as RealizedCare, and strives to meet the increased demand for evidence-based, more scalable, impactful and economically viable solutions for a range of mental and behavioral health burdens, beginning with chronic pain.

Key Points: 
  • RealizedCare introduces an advanced care management platform powered by DTx technology.
  • The platform's approach, which combines DTx with traditional wraparound services, will unlock value-based chronic pain management at scale.
  • "Chronic pain is on the rise globally and the demand for holistic, multi-modal care via digital solutions is growing.
  • "We are thrilled to join RealizedCare and to enable this new offering, which supercharges the scalability and economic viability of traditional care management programs," said Brad Lawson, CEO, Fern Health.

ProPharma Launches an Integrated MedTech Organization Providing End-to-End Solutions for Innovators

Retrieved on: 
Thursday, November 16, 2023
Odyssey, Real-World Evidence, Data management, Safety, Digital therapeutics, Software, 2005 in television, MDR, Notified body, Companion, Medtech, LDT, U.S. FDA, Verification and validation, FDA, QMS, Medical device, Form FDA 483, Digital, Integrated Global System Model, Wearable computer, Geography, Development, RCO, Combination, SRL Diagnostics, Surveillance capitalism, Quality management, IVDR, Single-frequency network, RWE, Health technology, Pharmaceutical industry, Device

RALEIGH, N.C., Nov. 16, 2023 /PRNewswire-PRWeb/ -- ProPharma Group, the world's largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and quality compliance services for the life sciences industry, has today launched a new Integrated Global MedTech Practice to provide end-to-end solutions for medical technology companies.

Key Points: 
  • ProPharma Group has today launched a new Integrated Global MedTech Practice to provide end-to-end solutions for medical technology companies.
  • "ProPharma's new MedTech practice has extensive experience and offers scalable solutions tailored to client needs, regardless of size or geography" –Dr.
  • The MedTech organization includes Regulatory Strategy, Clinical Strategy and Development, Quality Management and Compliance, Market Access and Reimbursement, and Post Market Surveillance.
  • For more information about ProPharma Group's Global MedTech Practice and its suite of services, please visit https://www.propharmagroup.com/ .